Global Market Study on Bile Duct Cancer (Cholangiocarcinoma) Treatment

Jul 2017| PMR297A| Persistence Market Research

Report Highlights

Report Introduction

The report ‘Bile Duct Cancer (Cholangiocarcinoma) Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)’ is a comprehensive compilation on the bile duct cancer treatment market and contains exclusive information regarding the market analysis, growth and forecasts for the period 2017 to 2025. Bile ducts are a series of thin tubes that reach from the liver to the small intestine. The major function of bile ducts is to move a fluid called bile from the liver and gallbladder to the small intestine, where it helps digest the fats in food. Bile duct cancer starts when the healthy cells in the bile duct begin to grow out of control to form tumors. Cancer can develop in any part of the bile duct system and can be classified into three types based on the location -

Intrahepatic bile duct cancers: These cancers develop in the smaller bile duct branches inside the liver from the left and right hepatic branches. About 5% to 10% of bile duct cancers are intrahepatic.

Extrahepatic cholangiocarcinoma: These cancers develop in the part of the bile duct that is outside the liver. These are of two types:

Perihilar (also called hilar) bile duct cancers: These cancers develop at the hilum, where the left and right hepatic ducts have joined and are just leaving the liver. These are also called Klatskin tumors.
Distal bile duct cancers: These cancers are found further down the bile duct, closer to the small intestine.
Bile duct cancer is a type of biliary tract cancer, which also includes gall bladder cancer; however gall bladder cancer is not included in the scope of this report, which largely focuses on intrahepatic bile duct tumors, perihilar bile duct tumors, and distal bile duct tumors.

Report Inclusions

This report is divided into four distinct parts. The first section consists of the introduction to the bile duct cancer treatment market. The second section of the report consists of the regional bile duct cancer treatment market analysis and forecast. The third section contains the competitive landscape of the global bile duct cancer treatment market and gives a list of the important players operating in this niche market. The last section of the report consists of the global bile duct cancer treatment market analysis 2012-2016 and forecast 2017-2025 by region, by treatment type, by disease indication and by distribution channel.

In the introduction, the pertinent market numbers of the global bile duct cancer treatment market are given along with the CAGR for the forecast period 2017-2025. The introduction also contains an executive summary of this detailed report through which the report audiences can have a cursory glance at this vast market. The report also contains detailed definitions of bile duct cancer and its different types along with the definitions of the various kinds of treatments administered in cases of bile duct cancer. In addition, the introduction also lists the macroeconomic factors influencing the global bile duct cancer treatment market. An opportunity analysis of the global bile duct cancer treatment market is also presented in the introduction. Along with this, the regulatory scenarios of various regions in the global bile duct cancer treatment market are also listed. Also, a list of products that are in the pipeline for the treatment of bile duct cancer is also given in the introduction.

The second section of the report contains the regional bile duct cancer treatment market analysis and forecast. In this section, the regional drivers, restraints and trends are given so that the report audience knows what factors are aiding the growth of this market and what factors are hampering the growth of this market across the various assessed regions. Besides the drivers and restraints, the trends that are applicable in the global bile duct cancer treatment market are also discussed region-wise in this section of the report.

An important section of the report focuses on the competitive landscape of the global bile duct cancer treatment market. This part constitutes information on the key market players. This competition landscape gives a dashboard view of the key companies operating in the global bile duct cancer treatment market along with their important information and broad strategy adopted to stay as leaders in the global bile duct cancer treatment market. Each of the leading companies is also profiled individually and important information about the company such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis is presented.

The last section of the report contains the global bile duct cancer treatment market analysis and forecast as well as important market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the bile duct cancer treatment market.

Why should you invest in this report?

If you are ready to enter the global bile duct cancer treatment market, then this report is a comprehensive guide and will give you crystal clear insights into this vast and lucrative market. All the aspects of bile duct cancer treatment are covered in this report and information is also given on the important regions of the world where this market is likely to boom in the near future and during the forecast period of 2017-2025 so that you can plan your strategies accordingly. Besides, through this report, you can gain a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, then this report will help you gauge the strategies that your competitors have adopted to stay as leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

A tested and proven research methodology for accurate estimation of market performance

Our research methodology leverages both primary and secondary research to collect the relevant market data. We have analyzed the global bile duct cancer treatment market by considering the revenue through extensive primary research to understand the usage patterns, historic trends, problems faced by oncologists, the required treatment developments, and most preferred drugs. Key opinion leaders have been considered for primary research including experienced healthcare professionals in various healthcare facilities at a country level. These estimates have further been validated with drug manufacturers, distributors, and suppliers.

Extensive secondary research has been carried out to understand the epidemiology of bile duct cancer, treatment rate, adoption rate, regulatory scenarios, average selling price, reimbursement scenario, etc., by referring to published scientific literature from various databases such as the WHO, PubMed, Springer, and Wiley among many others. We have also analyzed various companies’ annual reports, investor presentations, SEC filings, 10k reports, and press releases to fetch substantial information about the market size, trends, opportunities, drivers, and restraints.

Market Segmentation

By Treatment Type

  • Gemcitabine Combination Therapy
  • 5-fluorouracil Combination Therapy
  • Capecitabine Combination Therapy
  • Gemcitabine Single Agent

By Services Spending

  • Radiation Therapy
  • Brachytherapy Services
  • External Beam Radiation Therapy (EBRT)
  • Surgery

Disease Indication

  • Intrahepatic Bile Duct Cancer
  • Extrahepatic Bile Duct Cancer
  • Perihilar Bile Duct Cancer
  • Distal Extrahepatic Bile Duct Cancer

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East Africa (MEA)
  • Table 1 : Drug Administration Reimbursement Rates
  • Table 2 : Brachytherapy Reimbursement Rates
  • Table 3 : Pipeline Analysis
  • Table 4 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 5 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
  • Table 6 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value (Units) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication
  • Table 7 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 8 : Brazil Study: Combination Therapy Drug Cost ($US)
  • Table 9 : Clinical Trials in Latin America
  • Table 10 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 11 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
  • Table 12 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value (Units) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication
  • Table 13 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 14 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 15 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
  • Table 16 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value (Units) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication
  • Table 17 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 18 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 19 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
  • Table 20 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value (Units) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication
  • Table 21 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 22 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 23 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
  • Table 24 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value (Units) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication
  • Table 25 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 26 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) 2012�2016 and Forecast 2017-2025 By Region
  • Table 27 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) 2012�2016 and Forecast 2017-2025 By Treatment
  • Table 28 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) 2012�2016 and Forecast 2017-2025 By Disease Indication
  • Table 29 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) 2012�2016 and Forecast 2017-2025 By Distribution Channel
  • Table 30 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Spending
  • Table 31 : Global Bile Duct Cancer (Cholangiocarcinoma) Service Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Region
  • Figure 1 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Split By Chemotherapy (2017)
  • Figure 2 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Split By Services (2017)
  • Figure 3 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Split By Disease Indication (2017)
  • Figure 4 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Split By Distribution Channel (2017)
  • Figure 5 : Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Revenue Share by Region (2017 E)
  • Figure 6 : United States Generic Drug Approval Regulation
  • Figure 7 : EU Centralized procedure for Generic Drug Approval Regulation
  • Figure 8 : Mutual Recognition Procedure in Europe For Approval of Generic Drug
  • Figure 9 : Japan Decentralized Procedure For Approval of Generic Drug
  • Figure 10 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Treatment Type (2017)
  • Figure 11 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Disease Indication(2017)
  • Figure 12 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market
  • Figure 13 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Distribution Channel(2017)
  • Figure 14 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Country (2017)
  • Figure 15 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis, 2012�2016
  • Figure 16 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 17 : North America Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Country, 2017 & 2025
  • Figure 18 : North America Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 19 : U.S. Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 20 : U.S. Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 21 : Canada Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 22 : Canada Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 23 : Liver and Intrahepatic bile duct cancer, estimated new cases and deaths in United States
  • Figure 24 : Percent of new cases by age group in United States: Liver and Intrahepatic Bile Duct Cancer
  • Figure 25 : Liver and Intrahepatic Bile Duct Cancer Number of New Cases and Deaths per 100,000 People in United States
  • Figure 26 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Country
  • Figure 27 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Treatment Type
  • Figure 28 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Disease Indication
  • Figure 29 : North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 30 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Treatment Type (2017)
  • Figure 31 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Disease Indication(2017)
  • Figure 32 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market
  • Figure 33 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Distribution Channel(2017)
  • Figure 34 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Country (2017)
  • Figure 35 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis, 2012�2016
  • Figure 36 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 37 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Country, 2017 & 2025
  • Figure 38 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 39 : Brazil Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 40 : Brazil Bile Duct Cancer Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 41 : Mexico Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 42 : Mexico Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 43 : Rest of Latin America Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 44 : Rest of Latin America Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 45 : Brazil Study: Combination Therapy Drug Cost ($US)
  • Figure 46 : Clinical Trials in Latin America
  • Figure 47 : Estimated Annual Percent Change In Age-standardized Incidence From Gallbladder Cancer Registry (Latin America)
  • Figure 48 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Country
  • Figure 49 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Treatment Type
  • Figure 50 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Disease Indication
  • Figure 51 : Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 52 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Treatment Type (2017)
  • Figure 53 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Disease Indication(2017)
  • Figure 54 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market
  • Figure 55 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Distribution Channel(2017)
  • Figure 56 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Country (2017)
  • Figure 57 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis, 2012�2016
  • Figure 58 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 59 : Europe Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Country, 2017 & 2025
  • Figure 60 : Europe Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 61 : Germany Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 62 : Germany Bile Duct Cancer Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 63 : France Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 64 : France Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 65 : U.K. Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 66 : U.K. Bile Duct Cancer Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 67 : Spain Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 68 : Spain Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 69 : Italy Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 70 : Italy Bile Duct Cancer Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 71 : Benelux Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 72 : Benelux Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 73 : Poland Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 74 : Poland Bile Duct Cancer Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 75 : Russia Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 76 : Russia Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 77 : Rest of Europe Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 78 : Rest of Europe Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 79 : Estimated Incidence and Mortality of Gall Bladder and Extra Hepatic Bile Duct Cancer, 2012
  • Figure 80 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Country
  • Figure 81 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Treatment Type
  • Figure 82 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Disease Indication
  • Figure 83 : Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 84 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Treatment Type (2017)
  • Figure 85 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Disease Indication(2017)
  • Figure 86 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market
  • Figure 87 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Distribution Channel(2017)
  • Figure 88 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Country (2017)
  • Figure 89 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis, 2012�2016
  • Figure 90 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 91 : APAC Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Country, 2017 & 2025
  • Figure 92 : APAC Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 93 : China Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 94 : China Bile Duct Cancer Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 95 : India Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 96 : India Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 97 : Australia and New Zealand Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 98 : Australia and New Zealand Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 99 : ASEAN Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 100 : India Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 101 : Japan Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 102 : Japan Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 103 : Rest of Asia Pacific Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 104 : Rest of Asia Pacific Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 105 : Annual Incidence of Cholangiocarcinoma per 100,000 in Asia Pacific
  • Figure 106 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Country
  • Figure 107 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Treatment Type
  • Figure 108 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Disease Indication
  • Figure 109 : APAC Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 110 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Treatment Type (2017)
  • Figure 111 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Disease Indication(2017)
  • Figure 112 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market
  • Figure 113 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Distribution Channel(2017)
  • Figure 114 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Value Share By Country (2017)
  • Figure 115 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Analysis, 2012�2016
  • Figure 116 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 117 : MEA Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Country, 2017 & 2025
  • Figure 118 : MEA Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 119 : GCC Countries Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 120 : GCC Countries Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 121 : India Bile Duct Cancer (Cholangiocarcinoma) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 122 : South Africa Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 123 : Rest of MEA Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 124 : Rest of MEA Bile Duct Cancer (Cholangiocarcinoma) Market Absolute $ Opportunity, 2017�2025
  • Figure 125 : Annual Incidence of Liver Cancer per 100,000 in MEA
  • Figure 126 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Country
  • Figure 127 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Treatment Type
  • Figure 128 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Disease Indication
  • Figure 129 : MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 130 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Country, 2017 & 2025
  • Figure 131 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 132 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis By Region, 2017�2025
  • Figure 133 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Country, 2017 & 2025
  • Figure 134 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 135 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis By Treatment Type, 2017�2025
  • Figure 136 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Disease Indication, 2017 & 2025
  • Figure 137 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Disease Indication, 2016�2025
  • Figure 138 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis By Treatment Type, 2017�2025
  • Figure 139 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Share Analysis (%) By Distribution Channel, 2017 & 2025
  • Figure 140 : Global Bile Duct Cancer (Cholangiocarcinoma) Market Y-o-Y Growth (%) By Country, 2016�2025
  • Figure 141 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Attractiveness Analysis By Distribution Channel, 2017�2025
  • Figure 142 : Global Historical Market Size and Y-o-Y, 2012 - 2016
  • Figure 143 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Absolute $ Opportunity (US$ Mn), 2017�2025
  • Figure 144 : Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Absolute $ Opportunity, 2012�2025

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report